LABT (LABT)

NASDAQ: LABT · USD

$0.29

-0.00 (-0.4%)· Recorded snapshot

Market cap	675.6K
Net income (ttm)	-9M
EPS (ttm)	-$10.2
Shares out	2.4M
Volume	1,776,586

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -9M
EPS (ttm): -$10.2
Market cap: 675.6K

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	持有

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-402.8

P25 n/aP50 n/aP75 n/a

ROIC-166.2

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All LABT indicators

Market & fundamental data

Available fields

144

Groups with data

Currency

USD

Showing 144 of 144 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0002079272
Country	United States
Country code	US
CUSIP number	51255A201
Earnings date	2026-11-18
Earnings time	bmo
Enterprise value	$-3.8M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-10-09
Fiscal year end	December
Founded	2006
Industry	Biotechnology
Is primary listing	Yes
Is SPAC	No
ISIN number	US51255A2015
Last earnings date	2026-08-14
Last refreshed	2026-10-28
Last stock split date	2026-06-22
Last stock split type	Reverse
Market cap	$675,598
Market cap category	Nano-Cap
Next earnings date	2026-11-18
Price	$0.29
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	LABT
U.S. state	Florida
Website	https://lakewoodamedex.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-3,577.68%
FCF / EV yield	91.2%
FCF yield	-527.23%
P/B ratio	0.14x
Price / tangible book value	0.15x
Sector forward P/E	23.56x
Sector P/E	50.13x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
ROA	-139.4%
ROCE	-167.83%
ROE	-402.84%
ROIC	-166.2%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	2
Net income growth years	2
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Depreciation and amortization	$4,634
EBIT	$-7.3M
EBITDA	$-7.3M
EPS	$-10.20
FCF per share	$-1.47
Financing cash flow	$6.8M
Free cash flow	$-3.5M
Free cash flow minus SBC	$-7.3M
Investing cash flow	$-2M
Net cash flow	$1.3M
Net income	$-9M
Operating cash flow minus SBC	$-7.3M
Operating income	$-7.3M
Stock-based compensation	$3.8M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	$2.00
Debt / equity	0.02
Interest coverage	-58.4
Long-term assets	$114,710
Long-term liabilities	$0
Net cash (debt)	$4.5M
Net cash / market cap	678.09%
Net debt / equity	-1.04
Piotroski F-Score	2
Property, plant and equipment	$106,889
Shareholders' equity	$4.3M
Tangible book value	$4.3M
Tangible book value per share	$2.00
Total assets	$5M
Total cash	$4.6M
Total debt	$101,619
Total liabilities	$628,926

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current assets	$4.8M
Current liabilities	$628,926
Current ratio	7.7
Net working capital	$-266,782
Quick ratio	7.29
Working capital	$4.2M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-27.02%
Dividend yield	0%
Shareholder yield	-27.02%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1D price change	-0.38%
1M price change	-83.23%
1M total return	-83.23%
1W price change	-51.5%
1W total return	-51.5%
20-day SMA	$0.63
3M price change	-88.8%
3M total return	-88.8%
50-day SMA	$1.47
52-week high	$98.20
52-week high date	2026-04-23
52-week low	$0.24
52-week low date	2026-10-27
6M price change	-99.23%
6M total return	-99.23%
All-time high	$98.20
All-time high date	2026-04-23
All-time low	$0.24
All-time low date	2026-10-27
Average true range (ATR)	$0.13
Average volume	2.9M
Beta (1Y)	-0.54
Change from 52-week high	-99.71%
Change from 52-week low	19.29%
Change from all-time high	-99.71%
Change from all-time low	17.2%
Change from open	6.58%
Day's gap	-6.53%
Dollar volume	$506,505
High price	$0.29
Low price	$0.26
Monthly RSI	0
Open price	$0.27
Position in 52-week range	85.31%
Premarket change	-5.66%
Premarket close	$0.29
Premarket price	$0.27
Premarket volume	383.6K
Previous close	$0.29
Price vs 20-day SMA	-55.31%
Price vs 50-day SMA	-80.92%
Relative volume	0.62
RSI	17.85
Sharpe ratio	-4.08
Sortino ratio	-4.99
Volume	1.8M
Weekly RSI	3.27

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	847.7K
Float percentage	35.77%
Shares change (QoQ)	102.96%
Shares change (YoY)	27.02%
Shares held by insiders	51.19%
Shares held by institutions	5.38%
Shares outstanding	2.4M
Short % of float	15.42%
Short % of shares	5.52%
Short ratio	0.1 days

Deeper analysis on LABT

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this LABT report

Is a complete LABT research report available?

No complete published report is available for LABT (LABT) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

LABT (LABT)

Price

Financial snapshot

Fair-value bridge

Latest news · LABT

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All LABT indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on LABT

Frequently asked questions